logo-image

Tetiana has over 10 years of experience during which she has advised on all aspects of Ukrainian competition law: general competition compliance, merger control, vertical and collaborative agreements, abuse of dominance, as well as on unfair competition and consumer protection issues. She regularly represents clients before the Antimonopoly Committee of Ukraine in investigations and sector inquiries, develops competition compliance programs, and delivers training to client management and sales & marketing employees.

Ms. Vovk has had experience working in multi-national teams advising on EC and national competition law in global cross-border projects while employed by a leading European law firm.

Recognition:
  • Since 2008, Tetiana has been listed in the Best Lawyers Directory as a recognized expert in antitrust law.
  • Since 2008, Tetiana has been listed in the Best Lawyers Directory as a recognized expert in antitrust law.
Read more Hide
Education:
  • Kyiv National Taras Shevchenko University, Master of Law, 2001
  • Central European University, LL.M., International Business Law, 2005
  • King's College London, EC Competition Law (MA), 2009
Languages:
English, Russian, Ukrainian
Membership and activities:
  • The Ukrainian Bar Association
  • The International Bar Association
Representative experience:
  • obtaining merger clearances in the Aspen/AstraZeneca, Augusta Westland/Tata Sons, Allergan/Pfizer, Dow/DuPont, Francisco Partners/Dell, Geely/Volvo, Koch/Guardian, Microsoft/Skype, Sanofi/Google diabetes JV, Seagate/Samsung Electronics HDD Business, UTC/Riello, and Vivendi/Dailymotion transactions; 
  • assisted Teva in obtaining merger and antitrust clearance in transactions involving Allergan, Barr, Cephalon, Procter & Gamble, and ratiopharm;
  • advised Dow Agrosciences on competition issues related to its distribution arrangement with Syngenta, including on obtaining the relevant clearance;
  • counselled ABB, Bayer, Coty, Leroy Merlin Ukraine, L'Oreal, Metro Cash & Carry, Nestlé, Nissan Motor, Philip Morris, Shell, Tetra Pak, Teva, Toyota Ukraine, and the Walt Disney Company on:

    - contractual arrangements: assessment of the distribution agreements (including online trading issues), direct supplies, franchising; marketing services, merchandizing, and category management arrangements; joint product research and development (R&D) agreements, joint manufacture and distribution, and information exchange arrangements;

    - unilateral commercial practices: pricing, discounting (including loyalty rebates), special sales campaigns, supply and payment terms differentiation, product launches; assessment of marketing and advertising terms, and materials for compliance with unfair competition rules;

    - competition compliance issues with a special focus on the pharmaceutical, the automotive, and retail industries; and

    - other issues arising during the AMC inspection, investigations, and inquiries.

  • obtaining merger clearances in the Aspen/AstraZeneca, Augusta Westland/Tata Sons, Allergan/Pfizer, Dow/DuPont, Francisco Partners/Dell, Geely/Volvo, Koch/Guardian, Microsoft/Skype, Sanofi/Google diabetes JV, Seagate/Samsung Electronics HDD Business, UTC/Riello, and Vivendi/Dailymotion transactions
  • assisted Teva in obtaining merger and antitrust clearance in transactions involving Allergan, Barr, Cephalon, Procter & Gamble, and ratiopharm;
  • advised Dow Agrosciences on competition issues related to its distribution arrangement with Syngenta, including on obtaining the relevant clearance;
  • counselled ABB, Bayer, Coty, Leroy Merlin Ukraine, L'Oreal, Metro Cash & Carry, Nestlé, Nissan Motor, Philip Morris, Shell, Tetra Pak, Teva, Toyota Ukraine, and the Walt Disney Company on:

- contractual arrangements: assessment of the distribution agreements (including online trading issues), direct supplies, franchising; marketing services, merchandizing, and category management arrangements; joint product research and development (R&D) agreements, joint manufacture and distribution, and information exchange arrangements;

- unilateral commercial practices: pricing, discounting (including loyalty rebates), special sales campaigns, supply and payment terms differentiation, product launches; assessment of marketing and advertising terms, and materials for compliance with unfair competition rules;

- competition compliance issues with a special focus on the pharmaceutical, the automotive, and retail industries; and

- other issues arising during the AMC inspection, investigations, and inquiries.

Read more Hide
write to us